Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Migraine Cocktail in Pediatric ED
NCT06083571Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ketorolac in migraine (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Change from baseline in pain on the 10 point Faces Pain Scale-Revised at 120 months. Started Jan 2024; status: terminated.
02
Drugs
ketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06083571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06083571.